Motor neuron dysfunctions in the frontotemporal lobar degeneration spectrum: A clinical and neurophysiological study

被引:20
|
作者
Cerami, C. [1 ,2 ,3 ]
Marcone, A. [2 ,3 ]
Crespi, C. [1 ,2 ]
Iannaccone, S. [2 ,3 ]
Marangoni, C. [3 ]
Dodich, A. [1 ,2 ]
Giusti, M. C. [3 ]
Zamboni, M. [3 ]
Golzi, V. [3 ]
Cappa, S. F. [2 ,4 ]
机构
[1] Univ Vita Salute San Raffaele, Milan, Italy
[2] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy
[3] Hosp San Raffaele, Dept Clin Neurosci, Neurorehabil Unit, I-20132 Milan, Italy
[4] Ist Univ Super, Pavia, Italy
关键词
Frontotemporal lobar degeneration; Frontotemporal dementia; Motor neuron dysfunction; Amyotrophic lateral sclerosis; Electromyography; Pyramidal signs; AMYOTROPHIC-LATERAL-SCLEROSIS; CORTICOBASAL DEGENERATION; HEXANUCLEOTIDE REPEAT; BEHAVIORAL VARIANT; DEMENTIA; ALS; CRITERIA; DISEASE; IMPAIRMENT; DIAGNOSIS;
D O I
10.1016/j.jns.2015.02.039
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although only a few frontotemporal lobar degeneration (FTLD) patients develop frank amyotrophic lateral sclerosis (ALS), motor neuron dysfunctions (MNDys) occur in a larger proportion of patients. The aim of this study is to evaluate MNDys and ALS in a sample of consecutively enrolled sporadic FTLD patients. Methods: Clinical and neurophysiological evaluations (i.e. needle electromyography) assessed lower (LMN) and upper (UMN) motor neuron function at the baseline in 70 probable FTLD patients (i.e., 26 behavioural variant-bvFTD, 20 primary progressive aphasias-PPAs and 24 corticobasal syndrome-CBS). To obtain a more accurate estimation, quantitative scales were also applied (i.e. ALSFRS-r and UMN scale). Patients were screened for MAPT, GRN and C9orf72 mutations. A mean clinical follow-up of 27.8 +/- 22.4 months assessed MNDys progression and the clinical presentation of ALS. Results: Five genetic cases were identified. Within the sample of sporadic patients, a relative low rate of FTLD patients was diagnosed as probable ALS (5%), while a higher proportion of patients (17%) showed clinical and neurophysiological MNDys. Thirteen patients (20%) presented with isolated clinical signs of LMN and/or UMN dysfunction, and 8 patients (12%) showed neurogenic changes at the electromyography. No differences in FTLD phenotype and disease duration were found between MNDys positive and negative patients. Clinical MNDys were highly associated with positive electromyographic findings. At follow-up, no MNDys positive patient developed ALS. Conclusion: Neurophysiological and clinical examinations revealed mild MNDys in FTLD patients not fulfilling criteria for ALS. This condition did not evolve at a mean follow-up of two years. These results, indicating a subclinical degeneration of corticospinal tracts and lower motor neurons, suggest that FTLD patients may be more at risk of MNDys than the general population. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 50 条
  • [21] White Matter Damage in Frontotemporal Lobar Degeneration Spectrum
    Agosta, F.
    Scola, E.
    Canu, E.
    Marcone, A.
    Magnani, G.
    Sarro, L.
    Copetti, M.
    Caso, F.
    Cerami, C.
    Comi, G.
    Cappa, S. F.
    Falini, A.
    Filippi, M.
    CEREBRAL CORTEX, 2012, 22 (12) : 2705 - 2714
  • [22] Clinical and Imaging Features of Sporadic and Genetic Frontotemporal Lobar Degeneration TDP-43 A and B
    Coulborn, Sean
    Schafer, Rhiana
    Roy, Ashlin R. K.
    Sokolowski, Andrzej
    Cryns, Noah G.
    Leichter, Dana
    Lago, Argentina Lario
    Ramos, Eliana Marisa
    Cobigo, Yann
    Spina, Salvatore
    Grinberg, Lea T.
    Geschwind, Daniel H.
    Gorno-Tempini, Maria L.
    Kramer, Joel H.
    Rosen, Howard J.
    Miller, Bruce L.
    Seeley, William W.
    Perry, David C.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2025,
  • [23] New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
    Boxer, Adam L.
    Gold, Michael
    Feldman, Howard
    Boeve, Bradley F.
    Dickinson, Susan L. -J.
    Fillit, Howard
    Ho, Carole
    Paul, Robert
    Pearlman, Rodney
    Sutherland, Margaret
    Verma, Ajay
    Arneric, Stephen P.
    Alexander, Brian M.
    Dickerson, Bradford C.
    Dorsey, Earl Ray
    Grossman, Murray
    Huey, Edward D.
    Irizarry, Michael C.
    Marks, William J.
    Masellis, Mario
    McFarland, Frances
    Niehoff, Debra
    Onyike, Chiadi U.
    Paganoni, Sabrina
    Panzara, Michael A.
    Rockwood, Kenneth
    Rohrer, Jonathan D.
    Rosen, Howard
    Schuck, Robert N.
    Soares, Holly D.
    Tatton, Nadine
    ALZHEIMERS & DEMENTIA, 2020, 16 (01) : 131 - 143
  • [24] Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy
    Behrouzi, Roya
    Liu, Xiawei
    Wu, Dongyue
    Robinson, Andrew C.
    Tanaguchi-Watanabe, Sayuri
    Rollinson, Sara
    Shi, Jing
    Tian, Jinzhou
    Hamdalla, Hisham H. M.
    Ealing, John
    Richardson, Anna
    Jones, Matthew
    Pickering-Brown, Stuart
    Davidson, Yvonne S.
    Strong, Michael J.
    Hasegawa, Masato
    Snowden, Julie S.
    Mann, David M. A.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 33
  • [25] Loss of Insight in Syndromes Associated with Frontotemporal Lobar Degeneration: Clinical and Imaging Features
    Bracca, Valeria
    Premi, Enrico
    Cotelli, Maria Sofia
    Micheli, Anna
    Altomare, Damiele
    Cantoni, Valentina
    Gasparotti, Roberto
    Borroni, Barbara
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2025, 33 (04) : 450 - 462
  • [26] Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
    Murley, Alexander G.
    Coyle-Gilchrist, Ian
    Rouse, Matthew A.
    Jones, P. Simon
    Li, Win
    Wiggins, Julie
    Lansdall, Claire
    Rodriguez, Patricia Vazquez
    Wilcox, Alicia
    Tsvetanov, Kamen A.
    Patterson, Karalyn
    Ralph, Matthew A. Lambon
    Rowe, James B.
    BRAIN, 2020, 143 : 1555 - 1571
  • [27] Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
    Rohrer, Jonathan D.
    Lashley, Tammaryn
    Schott, Jonathan M.
    Warren, Jane E.
    Mead, Simon
    Isaacs, Adrian M.
    Beck, Jonathan
    Hardy, John
    de Silva, Rohan
    Warrington, Elizabeth
    Troakes, Claire
    Al-Sarraj, Safa
    King, Andrew
    Borroni, Barbara
    Clarkson, Matthew J.
    Ourselin, Sebastien
    Holton, Janice L.
    Fox, Nick C.
    Revesz, Tamas
    Rossor, Martin N.
    Warren, Jason D.
    BRAIN, 2011, 134 : 2565 - 2581
  • [28] Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72
    Davidson, Yvonne S.
    Barker, Holly
    Robinson, Andrew C.
    Thompson, Jennifer C.
    Harris, Jenny
    Troakes, Claire
    Smith, Bradley
    Al-Saraj, Safa
    Shaw, Chris
    Rollinson, Sara
    Masuda-Suzukake, Masami
    Hasegawa, Masato
    Pickering-Brown, Stuart
    Snowden, Julie S.
    Mann, David M.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [29] The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum
    Van Langenhove, Tim
    van der Zee, Julie
    Van Broeckhoven, Christine
    ANNALS OF MEDICINE, 2012, 44 (08) : 817 - 828
  • [30] Frontotemporal lobar degeneration: Study of a clinicopathological cohort
    Jose Gil, Maria
    Sagrario Manzano, Maria
    Luz Cuadrado, Maria
    Fernandez, Cristina
    Gomez, Elena
    Matesanz, Carmen
    Calero, Miguel
    Rabano, Alberto
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 58 : 172 - 180